P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845148.20140.63 |
| _version_ | 1797285849512017920 |
|---|---|
| author | G. Oñate M. Pratcorona A. Garrido A. Artigas A. Bataller M. Tormo M. Arnan S. Vives R. Coll O. Salamero F. Vall-Llovera A. Sampol A. Garcia M. Cervera S. Garcia Avila J. Bargay X. Ortin J. Esteve J. Sierra |
| author_facet | G. Oñate M. Pratcorona A. Garrido A. Artigas A. Bataller M. Tormo M. Arnan S. Vives R. Coll O. Salamero F. Vall-Llovera A. Sampol A. Garcia M. Cervera S. Garcia Avila J. Bargay X. Ortin J. Esteve J. Sierra |
| author_sort | G. Oñate |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:09:14Z |
| format | Article |
| id | doaj.art-1e5761179f21473bb4f55f14dbe9a4a8 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:09:14Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1e5761179f21473bb4f55f14dbe9a4a82024-03-02T07:47:35ZengWileyHemaSphere2572-92412022-06-01646446510.1097/01.HS9.0000845148.20140.63202206003-00464P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPYG. Oñate0M. Pratcorona1A. Garrido2A. Artigas3A. Bataller4M. Tormo5M. Arnan6S. Vives7R. Coll8O. Salamero9F. Vall-Llovera10A. Sampol11A. Garcia12M. Cervera13S. Garcia Avila14J. Bargay15X. Ortin16J. Esteve17J. Sierra181 Hematology, Hospital de la Santa Creu i Sant Pau1 Hematology, Hospital de la Santa Creu i Sant Pau1 Hematology, Hospital de la Santa Creu i Sant Pau1 Hematology, Hospital de la Santa Creu i Sant Pau3 Hematology, Hospital Clínic, Barcelona4 Hematology, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, Valencia5 Hematology, Institut Català d’Oncologia, Hospital Duran i Reynals, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Hospitalet de Llobregat6 Hematology, ICO-Hospital Germans Trias i Pujol, Badalona7 Hematology, ICO-Hospital Josep Trueta, Girona8 Hematology, Hospital Universitari Vall d’Hebron, VHIO9 Hematology, Hospital Universitari Mútua Terrassa, Barcelona10 Hematology, Hospital Son Espases, Palma de Mallorca11 Hospital Universitari Arnau de Vilanova, Lleida12 ICO-Hospital Joan XXIII, Tarragona13 Hematology, Hospital del Mar, Barcelona14 Hospital Son Llàtzer, Palma de Mallorca15 Hematology, Hospital Verge de la Cinta, Tortosa, Spain3 Hematology, Hospital Clínic, Barcelona1 Hematology, Hospital de la Santa Creu i Sant Pauhttp://journals.lww.com/10.1097/01.HS9.0000845148.20140.63 |
| spellingShingle | G. Oñate M. Pratcorona A. Garrido A. Artigas A. Bataller M. Tormo M. Arnan S. Vives R. Coll O. Salamero F. Vall-Llovera A. Sampol A. Garcia M. Cervera S. Garcia Avila J. Bargay X. Ortin J. Esteve J. Sierra P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY HemaSphere |
| title | P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY |
| title_full | P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY |
| title_fullStr | P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY |
| title_full_unstemmed | P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY |
| title_short | P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY |
| title_sort | p565 improved outcome of patiens with acute myeloid leukemia harboring flt3 mutation in the era of targeted therapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000845148.20140.63 |
| work_keys_str_mv | AT gonate p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT mpratcorona p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT agarrido p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT aartigas p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT abataller p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT mtormo p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT marnan p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT svives p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT rcoll p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT osalamero p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT fvallllovera p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT asampol p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT agarcia p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT mcervera p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT sgarciaavila p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT jbargay p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT xortin p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT jesteve p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy AT jsierra p565improvedoutcomeofpatienswithacutemyeloidleukemiaharboringflt3mutationintheeraoftargetedtherapy |